The proposed £7 billion takeover of Boots by the Weston family is facing uncertainty after recent negotiations between the Westons and the private equity owners of Boots stalled. Following a reduction in the offer by the Weston family, talks have broken down, putting the deal in jeopardy.

The Weston family, who have been pursuing the acquisition for several months, lowered their bid, prompting a rejection from Boots’ current owners. The private equity firms holding a majority stake have not accepted the revised terms, resulting in a deadlock.

Details regarding the specific reasons behind the Westons’ decision to reduce their offer have not been disclosed, though market observers suggest concerns about Boots’ current financial performance and broader economic factors may have influenced the move. The private equity owners have maintained that the previous offer better reflects the company’s valuation.

Boots, a prominent player in the UK retail pharmacy sector, has recently experienced challenges related to shifting consumer habits and increased competition in the healthcare market. These issues have contributed to cautious sentiment around the company’s future prospects.

Industry analysts note that the collapse of the deal, if confirmed, would leave Boots under its current ownership, prolonging uncertainty about its strategic direction. Both parties have yet to make formal statements about next steps, though sources indicate the Weston family may either seek to revise their proposal again or potentially withdraw from the acquisition altogether.

The outcome of these negotiations will be closely watched by investors, suppliers, and customers, as Boots remains a key fixture in the UK’s healthcare retail environment.